Recap: Chinook Therapeutics Q1 Earnings

Chinook Therapeutics (NASDAQ:KDNY) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:00 PM. Here’s what…

Chinook Therapeutics (NASDAQ:KDNY) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Chinook Therapeutics missed estimated earnings by 7.59%, reporting an EPS of $-0.85 versus an estimate of $-0.79.

Revenue was down $869 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11 which was followed by a 1.16% increase in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Chinook Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Cannabis Producer Vext Reports YoY Decline In Q1, Announces $2M Standby Credit Facility Ahead Of Ohio Rec Market Launch

Cannabis operator with vertical operations in Arizona and Ohio, Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) reported on Wednesday its first quarter financial results for the three months ended March 31, 2024."The first quarter of 2024 continued to present consumer-related challenges to all operators, with the Arizona market overall experiencing another decline in quarterly revenue," said Eric Offenberger, CEO of Vext.

CSE:VEXT